This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamanaka, H.
Right arrow Articles by Okamoto, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamanaka, H.
Right arrow Articles by Okamoto, K.

 Previous Article  |  Next Article 

Journal of Bacteriology, December 2001, p. 6961-6964, Vol. 183, No. 23
0021-9193/01/$04.00+0   DOI: 10.1128/JB.183.23.6961-6964.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Carboxy-Terminal Region Involved in Activity of Escherichia coli TolC

Hiroyasu Yamanaka,1 Hiroshi Izawa,2 and Keinosuke Okamoto2,*

Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro, Tokushima 770-8514,1 and Faculty of Pharmaceutical Sciences, Okayama University, Tsushima-naka, Okayama 700-8530,2 Japan

Received 29 June 2001/Accepted 10 September 2001


    ABSTRACT
Top
Abstract
Text
References

The Escherichia coli TolC acts as a channel tunnel in the transport of various molecules across the outer membrane. Partial-deletion studies of tolC revealed that the region extending from the 50th to the 60th amino acid residue from the carboxy terminus plays an important role in this transport activity of TolC.


    TEXT
Top
Abstract
Text
References

TolC, an outer membrane protein of Escherichia coli, functions as a transporter in multiple transport systems (3). For example, TolC interacts with the HlyD/HlyB complex to secrete hemolysin (20) and with the CvaA/CvaB complex to secrete colicin V (6). In addition to being involved in the secretion of these macromolecules, TolC functions in the export of small molecules such as antibiotics, sodium dodecyl sulfate (SDS), bile salts, and organic solvents by interacting with complexes such as EmrA/EmrB and AcrA/AcrB (2, 10, 12, 18).

These large and small molecules are secreted in a single step without stagnation in the periplasm. Recently, Yamanaka et al. (24) and Foreman et al. (4) found that TolC is also involved in the transportation of heat-stable enterotoxin I (STI) and STII of E. coli. These STs are synthesized as precursor proteins with an amino-terminal signal sequence and are translocated across the inner membrane via the Sec machinery (8, 14). In contrast to the secretory molecules which cross two membranes in a single step without stagnating in the periplasm, these STs, after being released into the periplasm, remain for a short period in this location (4, 13, 22). After being processed in the periplasm, these STs translocate across the outer membrane through the action of TolC. This suggests that TolC can also pump periplasmic components out into the medium.

In addition to having a secretory function, TolC participates in the uptake of colicin E1 (ColE1) from outside the cell into the periplasm (16, 21). However, the regions of TolC involved in these activities have not been established. In this study, we mutated the gene encoding the carboxy terminus of tolC and examined the efflux of STs and antibiotics and the influx of ColE1.

Function of mutant TolC. The tolC gene carried by pET11-STI-TolC (23) was mutated to delete amino acid residues at the carboxy terminus from the protein product. We generated a stop codon at target positions of TolC by PCR-based overlap extension mutagenesis using appropriate primers (5). The targets were the amino acid residues at positions 452, 442, 432, 422, and 412 of TolC. The mutations were verified by DNA sequencing. The mutant TolC proteins produced from these genes had deletions of 20, 30, 40, 50, and 60 amino acid residues from the carboxy terminus, respectively. The mutant plasmids were designated pET11-STI-TolC(Delta C20), pET11-STI-TolC(Delta C30), pET11-STI-TolC(Delta C40), pET11-STI-TolC(Delta C50), and pET11-STI-TolC(Delta C60), respectively.

The function of the mutant TolCs was examined by determining the sensitivity to acriflavine and novobiocin of the cells harboring these plasmids. Both antibiotics are excreted from cells by pumps which are composed of several proteins, including TolC (11). BL21-2, a derivative of BL21 whose tolC gene was mutated (24), was used as the host strain. Sensitivity was determined by an agar plate diffusion assay. Approximately 107 cells were spread on an L agar plate containing ampicillin (50 µg/ml). Sterile blank disks (6.4 mm in diameter) were placed on a lawn. A 20-µl solution of novobiocin (1 mg/ml; Sigma, St. Louis, Mo.) or acriflavine (1 mg/ml; Sigma) was pipetted onto each disk. The plates were incubated overnight at 37°C. The sensitivity of the cells to the substances was classified according to the size of the growth inhibition zone.

BL21-2 transformed with pET11-STI, which does not contain tolC (23), was sensitive to these inhibitors. In contrast, BL21-2 transformed with pET11-STI-TolC was tolerant (Table 1).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Sensitivities to antimicrobial agents of strains of an E. coli BL21 tolC mutant (BL21-2) harboring the indicated plasmids

The cells transformed with pET11-STI-TolC(Delta C20), pET11-STI-TolC(Delta C30), pET11-STI-TolC(Delta C40), and pET11-STI-TolC(Delta C50) were tolerant to the inhibitors, indicating that a deletion of less that 50 amino acid residues does not affect the activity of TolC. In contrast, the cells transformed with pET11-STI-TolC(Delta C60) were sensitive to both inhibitors (Table 1), indicating that the region extending from the 50th to the 60th amino acid from the carboxy terminus is necessary for TolC to excrete the inhibitors.

The sensitivity of the transformed cells to ColE1 was also examined by the disk assay. The concentration of ColE1 (Sigma) used was 100 µg/ml. As shown in Table 1, truncations at the 20th, 30th, 40th, and 50th amino acid residues did not affect ColE1 sensitivity, but the truncation at the 60th residue induced a complete loss of ColE1 sensitivity.

Assembly of mutant TolCs and association with the outer membrane. The native TolCs associate with the outer membrane and assemble to form a trimer (7). To examine whether TolC(Delta C60)s form trimers and associate with the outer membrane, we did cross-linking and membrane fractionation experiments.

BL21-2 cells harboring the plasmids were gently sonicated, and 300 µl of the sonicated suspension containing 5 mg of protein was removed to a new tube. One hundred microliters of 25 mM dimethyl suberimidate (DMS), a cross-linking reagent (19), was added to the tube, which was then incubated at 37°C for 10 min. The reaction was quenched by the addition of Tris-HCl (pH 7.4) to a final concentration of 50 mM. The samples were separated by SDS-polyacrylamide gel electrophoresis (PAGE) (9), and the TolC on the gel was detected by immunoblotting using the anti-TolC antiserum, which was prepared by the injection of a peptide (ELRKSAADRDAAFEK), corresponding to residues 16 to 30 from the amino-terminal end of TolC, into a rabbit.

The sample from BL21-2/pET11-STI-TolC was placed in lanes 1 and 2 of the gel shown in Fig. 1 and analyzed. A 51-kDa band was detected in the sample not treated with DMS (lane 1). The calculated molecular weight of TolC is 51,454. In the sample treated with DMS (lane 2), a band of 155 kDa, presumably representing TolC trimers, appeared.


View larger version (64K):
[in this window]
[in a new window]
 
FIG. 1.   Cross-linking of TolC exists in cells. Cells of E. coli BL21-2, the tolC mutant strain, transformed with the indicated plasmids were grown to the exponential phase in L broth at 37°C. The cultured cells were collected by centrifugation and suspended in phosphate-buffered saline. They were then disrupted by sonication. The solution containing the cell debris was treated with DMS to generate cross-linkages between associated proteins. The sample obtained was separated by SDS-PAGE, and the TolCs on the gel were detected by immunoblotting as described in the text. The bands indicated by black arrows are monomers of TolC, and those indicated by open arrows are trimers. Numbers along the right side indicate molecular masses in kilodaltons.

The TolC(Delta C60) sample not treated with DMS (lane 5) migrated to the 45-kDa position. TolC(Delta C60) treated with DMS (lane 6) produced a band of 135 kDa. This result showed that the mutant TolC(Delta C60)s associated to form a trimer.

To examine the association of TolC(Delta C60) with the outer membrane, the crude membrane fractions of BL21-2 harboring pET11-STI-TolC(Delta C60) were centrifuged through sucrose density gradients spanning 24 to 70%. A previous study showed that the outer membrane and inner membrane were recovered from the fractions containing 50 and 30% sucrose, respectively (15).

After centrifugation, the solution in the centrifugation tube was divided into fractions. All fractions were examined for the presence of TolC by immunoblotting. Both TolC(Delta C60) and wild-type TolC were located in tubes containing 50 to 58% sucrose (data not shown).

Secretion of STs through the mutant TolCs. Secretion of STs into the medium through the actions of mutant TolCs was examined by pulse-labeling (17). BL21-2 cells transformed with the derivatives of pET plasmids (Fig. 2) were labeled for 3 min with [35S]cysteine. After further incubation for 3 min (chase period), the cells were separated by centrifugation. The periplasmic fractions were prepared by treatment with polymyxin B (23). The culture supernatant and periplasmic fractions obtained were resolved by SDS-PAGE, and STs in the gels were detected by autoradiography.


View larger version (37K):
[in this window]
[in a new window]
 
FIG. 2.   Secretion of STI and STII from cells. The secretion of STs from cells was examined by the labeling method. Exponentially growing cells of BL21-2 harboring the indicated plasmid were treated with IPTG (isopropyl-beta -D-thiogalactopyranoside) and then labeled for 3 min with L-[35S]cysteine. The labeling was terminated by the addition of cold cysteine to the culture. Incubation was continued for 3 min (chase period), and then the culture supernatant was obtained by centrifugation. The periplasmic fractions of the cells were prepared by treatment with polymyxin B. These prepared fractions were treated with an SDS-dye solution and heated at 100°C for 10 min. The samples thus prepared were resolved by SDS-PAGE. Radioactive bands were detected by image analysis.

STI synthesized by the TolC-deficient cells transformed with pET11-STI was not released into the external medium and remained in the periplasm (Fig. 2A, lanes 1 and 5). In contrast, almost all STIs synthesized by the cells transformed with pET11-STI-TolC were secreted into the medium and the amount of STIs remaining in the periplasm was very small (lanes 2 and 6). Deletion of 50 amino acid residues at the carboxy terminus of TolC did not affect the secretion of STI (lanes 3 and 7). However, deletion of 60 residues markedly reduced the amount of STI secreted into the culture supernatant and the amount of STI remaining in the periplasm was very large (lanes 4 and 8).

The secretion of STII was also examined. The mutant plasmid pET11-STII-TolC(Delta C60) was obtained by mutagenesis from pET11-STII-TolC, which was prepared by inserting tolC into the HindIII-EcoRI site of pET11-STII (13). STII was not secreted from BL21-2/pET11-STII-TolC(Delta C60), and the STIIs remained in the periplasm (Fig. 2A, lanes 11 and 14).

Effect of replacement of Leu-412. The 60th amino acid residue from the carboxy-terminal end of TolC is leucine at position 412. We replaced the bases encoding Leu-412 of appropriate plasmids with those encoding proline and examined the properties of the mutant TolC [TolC(L412P)].

As shown in lane 4 of Fig. 1, TolC(L412P) formed trimers. Association of TolC(L412P) with the outer membrane was also confirmed by ultracentrifugation through a sucrose density gradient (data not shown).

E. coli BL21-2 transformed with the plasmid was sensitive to acriflavine and novobiocin and tolerant to ColE1 (Table 1). The activity of the mutant cells for the secretion of STI and STII into the culture supernatant was low compared with that of the wild type (Fig. 2B, lanes 3 and 8). A large amount of STs remained in the periplasm (Fig. 2B, lanes 6 and 10).

In this study, we showed that the region extending from the 50th to the 60th amino acid from the carboxy-terminal end is indispensable to TolC for expressing its export-import activity, although it is not required for the formation of the TolC trimer.

The TolC molecule can be divided into three domains: a beta -domain, an alpha -domain, and a mixed alpha -beta domain (1, 7). The beta -domain is embedded in the outer membrane. In contrast, the alpha -domain penetrates the periplasm and forms a 12-stranded antiparallel alpha -barrel. Some side chains of residues constituting the mixed alpha -beta domain interact with the alpha -domain through hydrogen bonds and van der Waals contacts. The region extending from the 50th to the 60th amino acid from the carboxy terminus is a part of the mixed alpha -beta domain that interacts with two strands of the alpha -domain (H3 and H4) in the periplasm. Our results suggest that this interaction may be important for TolC to express its activity.


    ACKNOWLEDGMENTS

This study was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan.


    FOOTNOTES

* Corresponding author. Mailing address: Faculty of Pharmaceutical Sciences, Okayama University, Tsushima-naka, Okayama, Okayama 700-8530, Japan. Phone: 81-86-251-7945. Fax: 81-86-251-7927. E-mail: okamoto{at}pheasant.pharm.okayama-u.ac.jp.


    REFERENCES
Top
Abstract
Text
References

1. Anderson, C., C. Hughes, and V. Koronakis. 2000. Chunnel vision. EMBO Rep. 1:313-318[CrossRef][Medline].
2. Aono, R., N. Tsukagoshi, and M. Yamamoto. 1998. Involvement of outer membrane protein TolC, a possible membrane of the mar-sox regulon, in maintenance and improvement of organic solvent tolerance of Escherichia coli K-12. J. Bacteriol. 180:938-944[Abstract/Free Full Text].
3. Benz, R., E. Maier, and I. Gentschev. 1993. TolC of Escherichia coli functions as an outer membrane channel. Zentbl. Bakteriol. 278:187-196.
4. Foreman, D., I. Martinez, G. Coombs, A. Torres, and Y. M. Kupersztoch. 1995. TolC and DsbA are needed for the secretion of STB, a heat-stable enterotoxin of Escherichia coli. Mol. Microbiol. 18:237-245[CrossRef][Medline].
5. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59[CrossRef][Medline].
6. Hwang, J., X. Zhong, and P. C. Tai. 1997. Interactions of dedicated export membrane proteins of the colicin V secretion system: CvaA, a member of the membrane fusion protein family, interacts with CvaB and TolC. J. Bacteriol. 179:6264-6270[Abstract/Free Full Text].
7. Koronakis, V., A. Sharff, E. Koronakis, B. Luisi, and C. Hughes. 2000. Crystal structure of the bacterial membrane protein TolC, central to multidrug efflux and protein export. Nature 405:914-919[CrossRef][Medline].
8. Kupersztoch, Y. M., K. Tachias, C. R. Moomaw, L. A. Dreyfus, R. Urban, C. Slaughter, and S. Whipp. 1990. Secretion of methanol-insoluble heat-stable enterotoxin (STB): energy- and secA-dependent conversion of pre-STB to an intermediate indistinguishable from the extracellular toxin. J. Bacteriol. 172:2427-2432[Abstract/Free Full Text].
9. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685[CrossRef][Medline].
10. Lomovskaya, O., and K. Lewis. 1992. emr, an Escherichia coli locus for multidrug resistance. Proc. Natl. Acad. Sci. USA 89:8938-8942[Abstract/Free Full Text].
11. Ma, D., D. N. Cook, J. E. Hearst, and H. Nikaido. 1994. Efflux pump and drug resistance in Gram-negative bacteria. Trends Microbiol. 2:489-493[CrossRef][Medline].
12. Nikaido, H. 1996. Multidrug efflux pumps of gram-negative bacteria. J. Bacteriol. 178:5853-5859[Free Full Text].
13. Okamoto, K., T. Baba, H. Yamanaka, N. Akashi, and Y. Fujii. 1995. Disulfide bond formation and secretion of Escherichia coli heat-stable enterotoxin II. J. Bacteriol. 177:4579-4586[Abstract/Free Full Text].
14. Okamoto, K., and M. Takahara. 1990. Synthesis of Escherichia coli heat-stable enterotoxin STp as a pre-pro form and role of the pro sequence in secretion. J. Bacteriol. 172:5260-5265[Abstract/Free Full Text].
15. Osborn, M. J., J. E. Gander, E. Parisi, and J. Carson. 1972. Mechanism of assembly of the outer membrane of Salmonella typhimurium. J. Biol. Chem. 247:3962-3972[Abstract/Free Full Text].
16. Stroud, R. M., K. Reiling, M. Wiener, and D. Freymann. 1998. Ion-channel-forming colicins. Curr. Opin. Struct. Biol. 8:525-533[CrossRef][Medline].
17. Studier, F. W., A. H. Rosenberg, J. J. Dunn, and J. W. Dubendorff. 1990. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185:60-89[Medline].
18. Thanassi, D. G., L. W. Cheng, and H. Nikaido. 1997. Active efflux of bile salts by Escherichia coli. J. Bacteriol. 179:2512-2518[Abstract/Free Full Text].
19. van der Goot, F. G., J. Ausio, K. R. Wong, F. Pattus, and J. T. Buckley. 1993. Dimerization stabilizes the pore-forming toxin aerolysin in solution. J. Biol. Chem. 268:18272-18279[Abstract/Free Full Text].
20. Wandersman, C., and P. Delepelaire. 1990. TolC, an Escherichia coli outer membrane protein required for hemolysin secretion. Proc. Natl. Acad. Sci. USA 87:4776-4780[Abstract/Free Full Text].
21. Webster, R. E. 1991. The tol gene products and the import of macromolecules into Escherichia coli. Mol. Microbiol. 5:1005-1011[Medline].
22. Yamanaka, H., M. Kameyama, T. Baba, Y. Fujii, and K. Okamoto. 1994. Maturation pathway of Escherichia coli heat-stable enterotoxin I: requirement of DsbA for disulfide bond formation. J. Bacteriol. 176:2906-2913[Abstract/Free Full Text].
23. Yamanaka, H., T. Nomura, Y. Fujii, and K. Okamoto. 1997. Extracellular secretion of Escherichia coli heat-stable enterotoxin I across the outer membrane. J. Bacteriol. 179:3383-3390[Abstract/Free Full Text].
24. Yamanaka, H., T. Nomura, Y. Fujii, and K. Okamoto. 1998. Need for TolC, an Escherichia coli outer membrane protein, in the secretion of heat-stable enterotoxin I across the outer membrane. Microb. Pathog. 25:111-120[CrossRef][Medline].


Journal of Bacteriology, December 2001, p. 6961-6964, Vol. 183, No. 23
0021-9193/01/$04.00+0   DOI: 10.1128/JB.183.23.6961-6964.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • DeVito, J. A. (2008). Recombineering with tolC as a Selectable/Counter-selectable Marker: remodeling the rRNA Operons of Escherichia coli. Nucleic Acids Res 36: e4-e4 [Abstract] [Full Text]  
  • Augustus, A. M., Celaya, T., Husain, F., Humbard, M., Misra, R. (2004). Antibiotic-Sensitive TolC Mutants and Their Suppressors. J. Bacteriol. 186: 1851-1860 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamanaka, H.
Right arrow Articles by Okamoto, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamanaka, H.
Right arrow Articles by Okamoto, K.